Izraēla -
ivrits -
Ministry of Health
סופרפקט דפו חודשיים
sanofi - aventis israel ltd - buserelin acetate 6.6 mg - rods for implant - buserelin - treatment of advanced hormone - dependent prostatic carcinoma.
Izraēla -
ivrits -
Ministry of Health
סופרפאקט דפו 3 חודשים
sanofi - aventis israel ltd - buserelin acetate - קנים להשתלה - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
Izraēla -
ivrits -
Ministry of Health
סופרפקט תרסיס לאף
sanofi - aventis israel ltd - buserelin as acetate 0.1 mg/actuations - solution - buserelin - treatment of advanced hormone dependent prostatic carcinoma. endometriosis. use in ivf. precocious puberty. leyomyoma uteri.
Izraēla -
ivrits -
Ministry of Health
זאלטראפ
sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.
Izraēla -
ivrits -
Ministry of Health
movement exercisers trainers
אי. טי. שיקום בע"מ - מומחה - tep to hip and knee, arthroscopy etc.
Izraēla -
ivrits -
Ministry of Health
continuous passive motion exercisers + accessories
בפקס בע"מ - מומחה - שיקום הגפיים
Izraēla -
ivrits -
Ministry of Health
infusion device/catheters,respiratory exerciser
י.גיל מדיקל בע"מ - רופא - לשמוש במח' מיון ואישפוז
Izraēla -
ivrits -
Ministry of Health
ליקסומיה 10 מקג
sanofi - aventis israel ltd - lixisenatide - תמיסה להזרקה - lixisenatide 10 mcg / 0.2 ml - lixisenatide
Izraēla -
ivrits -
Ministry of Health
ליקסומיה 20 מקג
sanofi - aventis israel ltd - lixisenatide - תמיסה להזרקה - lixisenatide 20 mcg / 0.2 ml - lixisenatide